Metraipolis › archive › dc_4a040a72d1bb
The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41629324
- DOI
- 10.1038/s41541-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T06:10:40.824Z
- SHA-256 of the archived text
f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561- Stable URL of this page
https://metraipolis.com/documento/dc_4a040a72d1bb
How to cite
The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324 — Europe PMC (en), https://europepmc.org/article/MED/41629324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a040a72d1bb (Metraipolis archive dc_4a040a72d1bb, sha256 f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561)
BibTeX
@misc{dc4a040a72d1bb,
title = {The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine — Europe PMC PMID:41629324},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41629324},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a040a72d1bb; sha256 f7f3a04842de1d7d916ab2b51821eb4db59b295657bb0f01fe9f7b6e399b2561},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41629324. Agents can read the archived copy with the MCP tool read_document.